Effectiveness and safety of Mobi-C for treatment of single-level cervical disc spondylosis: A RANDOMISED CONTROL TRIAL WITH A MINIMUM OF FIVE YEARS OF FOLLOW-UP

    loading  Checking for direct PDF access through Ovid



In order to evaluate the effectiveness of the Mobi-C implant in cervical disc degeneration, a randomised study was conducted, comparing the Mobi-C prosthesis arthroplasty with anterior cervical disc fusion (ACDF) in patients with single level cervical spondylosis.

Patients and Methods

From January 2008 to July 2009, 99 patients were enrolled and randomly divided into two groups, those having a Mobi-C implant (n = 51; 30 men, 21 women) and those undergoing ACDF (n = 48; 28 men, 20 women).The patients were followed up for five years, with the primary outcomes being the Japanese Orthopaedic Association score, visual analogue scale for pain and the incidence of further surgery. The secondary outcomes were the Neck Disability Index and range of movement (ROM) of the treated segment.


The incidence of further surgery was found to be statistically significant between the two groups (p = 0.49), with seven ACDF patients requiring further surgery and only one Mobi-C patient requiring re-operation. There were significant differences (p < 0.001) between the two groups in the ROM of the treated segment. However, both Mobi-C surgery and ACDF surgery were effective in improving the patient's clinical symptoms.


Take home message: Mobi-C implant surgery is a safe alternative to ACDF surgery in cervical disc degeneration.


Cite this article:Bone Joint J2016;98-B:829-3.

Related Topics

    loading  Loading Related Articles